Utterly Meaningless » Blog Archive » HPV VAX UPDATE

    Filed at 10:23 pm under by dcobranchi

    It appears that Merck is soon to have some competition.

    GlaxoSmithKline is getting closer to launching its challenge against Merck’s monopoly on cervical cancer vaccines.

    The British drugmaker GlaxoSmithKline (down $0.42 to $54.83, Charts) is just weeks away from filing an application for its experimental cervical cancer vaccine Cervarix to the Food and Drug Administration.

    One Response to “HPV VAX UPDATE”

    Comment by
    March 15th, 2007
    at 8:41 am

    YAY! Options are good.

    Cervical cancer is bad.